Home > Drug Search >
  • Targets: Transient receptor potential cation channel subfamily V member (TRPV6)
  •   > 
Drug Filter
Category:
chemistry (10) biology (8)
Status:
Approved (4) BLA Filing (1) Phase Ⅱ (5) Phase Ⅰ (8)
Clinical Stage:
Active (12) Discontinued (2)
Bio-Type:
Gene therapy (2) Oncolytic virus (2) Vaccine (2) Recombinant cytokines (1)
Company:
Merck Sharp & Dohme (1) National Cancer Institute (1) UCB (3) University of California (1) SiBiono (1) Shanghai Sunway Biotech (2) H. Lee Moffitt Cancer Center and Research Institute (1) University of Nebraska Medical Center (1) MultiVir (1) Acuvax (1) Astex Pharmaceuticals (1) Debiopharm Group (1) Pharmaleads (1) City of Hope National Medical Center (1) COTI (1) Soricimed (1) Aprea (1) MolMed (1) Cleveland Biolabs (1) Incuron (1) AC Immune (1)
Indication:
Acute myeloid Leukemia (AML) (1) Adjunct treatment for epilepsy (1) Alzheimer's disease (AD) (1) Epilepsy/Seizures (3) Lymphoma (1) Myelodysplastic syndrome (MDS) (1) Ovarian cancer (4) Partial seizures (2) Prostate cancer (2) Solid tumours (5) Nasopharyngeal cancer (2) Pain (1) Squamous cell carcinoma of head and neck cancer (SCCHN) (1) Mesothelioma (1) Liver cancer (1) Gastrointestinal cancer (1)
Country:
US (1) EU (1) CN (2)
Aprv. Year:
1999 (1) 2004 (1) 2006 (1) 2016 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top